Your daily hepatology brief, curated automatically.
LiverWatch scans PubMed every day and delivers a single concise email with the most relevant new articles in hepatology — filtered by your topics of interest and by journal quality (SJR ranking).
What you receive
One email, every morning, with what matters — nothing more.
Targeted topics
Pick from 16 hepatology subspecialties: MASH/MASLD, HCC, cirrhosis, viral hepatitis, cholestatic diseases, transplantation, fibrosis biomarkers, and more.
Quality first
Each article is ranked by its journal's SJR percentile (top 0.1% → Q4), so you decide the minimum tier per topic. Major general journals always pass.
Your schedule
Daily at the hour you choose (in your timezone), or weekly on Monday mornings. Already-seen articles are excluded automatically.
Built for hepatologists and researchers
Keeping up with the literature is non-negotiable, but PubMed search alerts are noisy and journal RSS feeds are scattered. LiverWatch consolidates both: one email, one place, signal over noise.
- Six article types: clinical trials, meta-analyses, narrative reviews, observational studies, guidelines, basic / translational research.
- Editorials, letters and errata excluded automatically.
- Preview the next digest at any time without sending it.
- No tracking, no ads. Your preferences stay on the server.
Hepatocellular carcinoma · 2 articles
Atezolizumab plus bevacizumab versus sorafenib in unresectable HCC: 5-year follow-up
N Engl J Med · top 0.1% · Clinical Trial
Surveillance imaging strategies for HCC in cirrhotic patients: an updated meta-analysis
J Hepatol · top 1% · Meta-analysis
MASH / MASLD · 1 article
Resmetirom in NASH with fibrosis: phase 3 long-term safety and efficacy
Hepatology · top 5% · Clinical Trial
Sample digest · your topics, your filters.
Ready to start?
Request access and, once approved, you’ll get a link to create your account. Already invited? Just sign in.